MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy
Julie Halkein(University of Liège), Ingrid Struman(University of Liège)
Cited by 492
Related Papers
MicroRNA-21 Exhibits Antiangiogenic Function by Targeting RhoB Expression in Endothelial Cells
|PLoS ONE|2011|251
PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin
|Nature Medicine|2014|105
hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells
|Cellular and Molecular Life Sciences|2020|56
The Antiangiogenic Factor, 16-kDa Human Prolactin, Induces Endothelial Cell Cycle Arrest by Acting at Both the G0–G1 and the G2–M Phases
|Molecular Endocrinology|2005|52
Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis
|Molecular Cancer|2010|28